These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
411 related items for PubMed ID: 23818356
1. Adjuvant chemotherapy after reduced craniospinal irradiation dose in children with average-risk medulloblastoma: a 5-year follow-up study. Wahba HA, Abu-Hegazy M, Wasel Y, Ismail EI, Zidan AS. J BUON; 2013; 18(2):425-9. PubMed ID: 23818356 [Abstract] [Full Text] [Related]
2. Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma. Packer RJ, Gajjar A, Vezina G, Rorke-Adams L, Burger PC, Robertson PL, Bayer L, LaFond D, Donahue BR, Marymont MH, Muraszko K, Langston J, Sposto R. J Clin Oncol; 2006 Sep 01; 24(25):4202-8. PubMed ID: 16943538 [Abstract] [Full Text] [Related]
3. Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Friedrich C, von Bueren AO, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann RD, Rutkowski S. Eur J Cancer; 2013 Mar 01; 49(4):893-903. PubMed ID: 23182688 [Abstract] [Full Text] [Related]
4. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study. Packer RJ, Goldwein J, Nicholson HS, Vezina LG, Allen JC, Ris MD, Muraszko K, Rorke LB, Wara WM, Cohen BH, Boyett JM. J Clin Oncol; 1999 Jul 01; 17(7):2127-36. PubMed ID: 10561268 [Abstract] [Full Text] [Related]